
浏览全部资源
扫码关注微信
纸质出版日期:2013
移动端阅览
陈卓, 于卫江. 注射用黄芪多糖对非小细胞肺癌放疗的作用及对机体免疫的影响[J]. 中国实验方剂学杂志, 2013,19(6):309-313.
CHEN Zhuo, YU Wei-jiang. Effect of Astragalus Polysaccharide Injection in Radiotherapy on Non-small Cell Lung Cancer and Human Immune Function[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(6): 309-313.
陈卓, 于卫江. 注射用黄芪多糖对非小细胞肺癌放疗的作用及对机体免疫的影响[J]. 中国实验方剂学杂志, 2013,19(6):309-313. DOI:
CHEN Zhuo, YU Wei-jiang. Effect of Astragalus Polysaccharide Injection in Radiotherapy on Non-small Cell Lung Cancer and Human Immune Function[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(6): 309-313. DOI:
目的: 观察注射用黄芪多糖(APS)对非小细胞肺癌三维适形放射治疗(3D-CRT)的疗效。 方法: 将100例确诊的Ⅰ~Ⅳ期非小细胞肺癌患者
随机分为中药联合放射治疗组(实验组
50例)和单纯放射治疗组(对照组
50例)
放疗采用三维适形放射治疗
治疗总剂量50~70 Gy
2 Gy/次
每周5次。中药选用注射用黄芪多糖250 mg加入生理盐水500 mL中静滴
放疗当日开始给药
每天1次
直至放疗结束后停药
疗程与放疗同步。比较两组的近期疗效、外周血象、免疫功能及生活质量。 结果: 实验组和对照组的总有效率分别为88.0%和74.0%
二者之间无显著差异
卡氏评分(Karnofsky performance scale
KPS)提高率分别是74.0%和26.0%
呈极显著差异(P<0.01)。实验组T细胞亚群治疗前后变化显著(P<0.05)
对照组治疗前后变化不明显。外周血常规实验组治疗前后只有中性粒细胞计数无明显变化
对照组治疗前后WBC和中性粒细胞计数差异显著(P<0.05)。两组间比较
治疗后有显著差异(P<0.05)。 结论: 注射用黄芪多糖可以降低3D-CRT治疗非小细胞肺癌患者放疗的副作用
同时可以提高患者机体的免疫水平。
Objective: To observe the effect of astragalus polysaccharides (APS) injection on 3-Dimensional conformal radiation therapy (3D-CRT) for non-small cell lung cancer (NSCLC). Method: One hundred stage I-IV NSCLC patients were randomly divided into experimental group (n=50) and control group (n=50).Parients in experimental group were treated by APS combined with radiotherapy while the control group only received radiotherapy.And both groups were treated by 3D-CRT
with the total dose of 50-70 Gy and 2 Gy a time
5 times a week.250 mg APS injection (traditional Chinese medicine) with the addition of 500 mL or physiological saline was used for intravenous drop.The whole treatment course was synchronized with the radiotherapy.The comparison on short-term efficacy
peripheral blood
immune function and quality of life were given to the two groups. Result: The total effective rate of the experimental group was 88.0% and that of the control group was 74.0%
and there was no significant difference between the two groups.However
the increase rate of Karnofsky performance scale (KPS) for the two groups is 74.0% and 26.0%
respectively
showing extremely significant difference(P<0.01).T cell subset in the experimental group changes significantly before and after treatment (P<0.05) while there is no significant difference in the control group.Only neutrophilic granulocyte counting in the experimental group of peripheral blood routine has no significant change
while WBC counting before and after treatment and neutrophilic granulocyte counting in the control group have significant difference (P<0.05).There is significant difference between the experimental group and the control group after treatment(P<0.05). Conclusion: APS injection can reduce the side effects of 3D-CRT treatment for patients with NSCLC
meanwhile
it can improve the immunity of patients.
0
浏览量
5
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621